Navigation Links
Laureate Pharma Secures $20 Million to Enhance and Grow Biopharmaceutical Contract Manufacturing Business
Date:10/6/2010

ot require other Laureate services.  Laureate will enhance sample management procedures, upgrade and add new instrumentation to offer a full range of testing required to characterize protein products.  
  • Expanding mammalian cell line creation services; in 2011, Laureate will offer access to a variety of protein expression systems that can be selected based on the specific characteristics and requirements of the protein product.   Additionally, the Company plans to add cGMP cell banking services.
  • Adopting new quality systems technologies including new systems to manage inventory, deviations, and calibration and validation.  In addition, the Company will acquire a new software solution that will enable it to assemble documentation for clients in an eCTD format.  Finally, Laureate will expand its regulatory affairs unit to assist clients in the preparation of data summaries, batch reports and regulatory submissions.

  • Laureate Pharma has added 10 new jobs since bringing on a new CEO and a new Vice President of Business Development and plans to fill 50 more positions when working at capacity.

    About Laureate Pharma

    Laureate Pharma is a full-service biopharmaceutical contract development and manufacturing organization.  Laureate's scientists are expert in process development and cGMP production of therapeutic proteins including monoclonal antibodies and Fc-fusion proteins.  In addition, the company's portfolio of services includes aseptic filling, cell line development, analytical and stability testing, and regulatory support.  Laureate has served a global client base from its Princeton, New Jersey facility since 1981 and is a portfolio company of Saints Capital, LLC.

    About Saints Capital, LLC

    Saints Capital is a leading direct secondary acquirer of venture capital and private equity investments in emerging growth companies around the globe. It a
    '/>"/>

    SOURCE Laureate Pharma, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
    2. Thomson Reuters Predicts Nobel Laureates
    3. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
    4. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
    5. AstraZeneca and the Sacramento County Pharmacy Provide Free Medicines to Eligible California Patients
    6. Lotus Pharmaceuticals Retains Sichenzia Ross Friedman Ference LLP as General Legal Counsel
    7. ISTA Pharmaceuticals Reports Positive Preliminary Results from its Phase 1/2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis
    8. Nautilus Neurosciences and Mission Pharmacal Announce Exclusive Co-Promotion Agreement for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine to the Womens Health Market
    9. Reportlinker Adds US Pharmaceutical Market Overview - Healthcare reform, economic pressures and the patent cliff set to impact Pharma
    10. Octapharma USA Launches Web Resource for von Willebrand Disease Healthcare Professionals and Patients
    11. MAP Pharmaceuticals Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/17/2014)... 2014 STAAR Surgical Company (NASDAQ: ... implantable lenses and delivery systems for the eye, today ... 2014 Medical Technology & Diagnostics Forum in ... on Thursday, November 20 at 12:30 p.m. PT/3:30 p.m. ... overview of the Company,s current business trends, financial results, ...
    (Date:11/17/2014)... Calif. , Nov. 17, 2014 Asterias ... in the emerging field of regenerative medicine, today announced ... of Research and Development, will participate in a live ... Regenerative Medicine (CIRM) discussing the latest progress in stem ... The CIRM Google Hangout session is scheduled for Tuesday, ...
    (Date:11/17/2014)... 17, 2014  CTI BioPharma Corp. (CTI) (NASDAQ and MTA: ... investor conferences. Jefferies 2014 Global Healthcare Conference ... EST, London, England . ... December 3 at 9:00 a.m. EST, New York, ... webcast live and available for replay after the presentation. The webcast ...
    Breaking Medicine Technology:STAAR Surgical To Present At The Canaccord Genuity 2014 Medical Technology & Diagnostics Forum 2Asterias Biotherapeutics to Participate in Live Google Hangout Discussion of Stem Cell-Based Therapies for Spinal Cord Injury 2CTI BioPharma to Present at the Upcoming Investor Conferences 2
    ... Edge EHR Corp., EDGE, a provider of Dental ... to announce the release of edgeDMS™ for ... leverage the awesome power of the Apple® iPad. ... (Logo:   http://photos.prnewswire.com/prnh/20100310/AQ68604LOGO ) The ...
    ... Calif., Dec. 21, 2010 Jazz Pharmaceuticals, Inc. (Nasdaq: ... States Patent and Trademark Office (USPTO) has issued a ... "Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for ... is also listed in the FDA,s Approved Drug Products ...
    Cached Medicine Technology:Edge EHR Corp. Announces edgeDMS for iPad, Native Touch-Based Clinical Charting Software for the Paperless Dental Office. 2Jazz Pharmaceuticals Announces New Patent Issued for Sodium Oxybate 2
    (Date:11/18/2014)... Cristcot Inc., a global life sciences ... specialized drug delivery systems, today announced that the ... for the technology, which encompasses the company’s commercially ... patent was awarded to the inventor Jennifer Davagian ... to Cristcot Inc. The patented technology, titled “Method ...
    (Date:11/18/2014)... Medicationdiscountcard.com's blog offers health ... company's reputation for helping consumers save money at ... offer at http://blog.medicationdiscountcard.com/ . , Consumers need ... Affordable Care Act and the state health benefit ... about a variety of prescription drug and health ...
    (Date:11/18/2014)... HealthDay Reporter MONDAY, Nov. 17, ... prove effective at lowering LDL ("bad") cholesterol levels for ... That,s the conclusion of a clinical trial presented ... Chicago. The drug, alirocumab, outperformed the on-the-market medication ... statins, Zetia, said lead researcher Dr. Patrick Moriarty, director ...
    (Date:11/18/2014)... 2014 (HealthDay News) -- Women who started smoking at ... chronic, severe menstrual pain, a new study suggests. ... While smoking has been suspected as a risk factor ... the authors of the new study said. The ... a long-term study of women,s health in Australia. About ...
    (Date:11/18/2014)... 18, 2014 Global Partnership ... the telehealth platform to bring quality healthcare to ... passion, GPT created Global Partnership for TeleHealth Missions ... existing telehealth network. GPTM focuses specifically on ... and disaster relief organizations. , Michael ...
    Breaking Medicine News(10 mins):Health News:Japanese Patent Office Grants Patent to Cristcot Inc. 2Health News:Medicationdiscountcard.com Building Virtual Library of Resources to Help Consumers Navigate Healthcare Landscape 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 3Health News:Study Ties Teen Smoking to Risk of Severe Menstrual Cramps 2Health News:Global Partnership for TeleHealth (GPT) is Focused on Using the telehealth Platform to Bring Quality Healthcare to Populations in Need Worldwide 2
    ... a History of Eating Disorders More at Risk for ... for Eating and Anxiety Disorders ( www.remudaranch.com ), the ... new pressure to look perfect while pregnant. "With the ... an increased pressure to look perfect and thin during ...
    ... is the only authorized online learning program ... Known for bringing innovation to the chiropractic ... only web-based seminar program dedicated exclusively to ... Online, the online learning system authorized by ...
    ... 19 Abbott announced today,that the U.S. ... the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for ... analyzer. , Cartridges for E3+, ... patient,s,metabolic state within a few minutes. The glucose ...
    ... Amazing Heat Pack by Comfort Now, Inc., a revolutionary ... pain relief for athletes, arthritics, chronic pain sufferers, premenstrual ... musclesBURLINGTON, Ontario, Jan. 19 Not since the 1920 ... aid product been released as The Amazing Heat Pack, ...
    ... Commitment to Healthy and Successful Vascular Access for ... Vascular Access(SM), the nation,s leading provider of vascular ... of managed vascular access centers has collectively ,touched, ... Lifeline Vascular Access managed center Nephrology Vascular Lab ...
    ... The 2008 Frost & Sullivan Technology Innovation Award ... presented to TECNIMED srl for pioneering THERMOFOCUS, the first ... available with a new, rapid, room temperature stabilization system. ... the company that has demonstrated technological superiority within its ...
    Cached Medicine News:Health News:Remuda Ranch Reports More Women Seek to Be Thin During Pregnancy 2Health News:Activator Methods Introduces Web-Based Seminar Program 2Health News:Abbott Receives FDA CLIA Waiver for Use of Five Additional Cartridges on the i-STAT Handheld Blood Analyzer 2Health News:Abbott Receives FDA CLIA Waiver for Use of Five Additional Cartridges on the i-STAT Handheld Blood Analyzer 3Health News:The Amazing Heat Pack: The Most Innovative First Aid Solution Since the Band-Aid 2Health News:Lifeline Vascular Access Treats a Quarter Million Patients 2Health News:Lifeline Vascular Access Treats a Quarter Million Patients 3Health News:TECNIMED Picks Up Frost & Sullivan Award for its Innovative THERMOFOCUS 2Health News:TECNIMED Picks Up Frost & Sullivan Award for its Innovative THERMOFOCUS 3Health News:TECNIMED Picks Up Frost & Sullivan Award for its Innovative THERMOFOCUS 4
    ... The Vitros 250 is ... meet requirements in multiple environments ... large hospitals, clinics and satellite ... features on-board dilution, and can ...
    The IMx system is an automated analyzer designed to perform microparticle enzyme immunoassay (MEIA), fluorescence polarization immunoassay (FPIA) and ion capture technologies....
    Architect i2000 is a flexible solution for your evolving laboratory providing high throughput and walkaway time with built-in flexibility....
    ... The Bayer Immuno 1 provides ... immunoassay instrument with over 50 ... endocrinology, tumor marker, therapeutic drug, ... can be performed on a ...
    Medicine Products: